Diagnosis and Treatment of Bacterial Vaginosis
Diagnosis
Bacterial vaginosis is diagnosed when three of the following four Amsel criteria are present: homogeneous white vaginal discharge, vaginal pH >4.5, positive whiff test (fishy odor with 10% KOH), and clue cells on microscopy. 1
Diagnostic Criteria
Clinical diagnosis requires 3 of 4 Amsel criteria: 1
- Homogeneous, white, noninflammatory discharge that smoothly coats the vaginal walls
- Vaginal pH greater than 4.5
- Fishy odor before or after addition of 10% KOH (whiff test)
- Clue cells present on microscopic examination
Gram stain is an acceptable alternative diagnostic method, determining the relative concentration of bacterial morphotypes characteristic of BV (Nugent score ≥4). 1
Culture of Gardnerella vaginalis is NOT recommended as it lacks specificity—G. vaginalis can be isolated from half of normal women. 1
Treatment for Symptomatic Non-Pregnant Women
For symptomatic bacterial vaginosis in reproductive-age women, oral metronidazole 500 mg twice daily for 7 days is the preferred first-line treatment with the highest cure rate of 95%. 1, 2
First-Line Treatment Options (Equivalent Efficacy)
Metronidazole 500 mg orally twice daily for 7 days achieves 95% cure rate and is the most effective regimen. 1, 2
Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days achieves 75-84% cure rate with minimal systemic side effects (serum concentrations <2% of oral doses). 1, 3, 2
Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days achieves 82% cure rate. 1, 3, 2
Alternative Regimens (Lower Efficacy)
Metronidazole 2g orally as a single dose achieves only 84% cure rate and should be reserved for compliance concerns. 1, 4, 3
Clindamycin 300 mg orally twice daily for 7 days is an alternative when metronidazole cannot be used. 1, 2
Tinidazole 2g once daily for 2 days OR 1g once daily for 5 days achieves 27-36% therapeutic cure rates (when requiring resolution of all 4 Amsel criteria plus Nugent score normalization). 5
Choosing Between Oral vs. Vaginal Routes
Oral metronidazole is preferred for maximum efficacy (95% vs. 75-82% for vaginal preparations). 1, 3
- Maximum efficacy is required
- Patient is at high risk for pregnancy complications (history of preterm delivery)
- Compliance with multi-day vaginal therapy is questionable
Choose vaginal route when: 3, 2
- Patient cannot tolerate systemic side effects (gastrointestinal upset, metallic taste)
- Intolerance (not allergy) to oral metronidazole exists
- Minimizing systemic drug exposure is desired
Critical Treatment Warnings
Patients MUST avoid alcohol during metronidazole treatment and for 24 hours after completion to prevent disulfiram-like reactions. 1, 4, 3, 2
Clindamycin cream is oil-based and weakens latex condoms and diaphragms—counsel patients accordingly. 1, 3, 2
Patients with true allergy to oral metronidazole should NOT receive metronidazole vaginally—use clindamycin instead. 3, 2
Management of Sexual Partners
Routine treatment of male sexual partners is NOT recommended, as multiple clinical trials demonstrate no influence on treatment response or recurrence rates. 1, 4, 3, 2
Follow-Up
Follow-up visits are unnecessary if symptoms resolve. 1, 3, 2
Recurrence is common—alternative regimens can be used for recurrent disease. 1, 3
For recurrent BV, extended metronidazole 500 mg twice daily for 10-14 days is recommended, followed by maintenance therapy with metronidazole gel twice weekly for 3-6 months if needed. 6
Special Populations
Pregnant Women
All symptomatic pregnant women require treatment regardless of pregnancy status. 1, 2
High-risk pregnant women (prior preterm delivery) should be evaluated for treatment even if asymptomatic, as treatment may reduce prematurity risk. 1, 2, 7
First trimester: Clindamycin vaginal cream is preferred due to metronidazole concerns. 4, 2
Second and third trimesters: Metronidazole 250 mg orally three times daily for 7 days is recommended. 4, 2, 7
Clindamycin cream should NOT be used during pregnancy due to increased risk of preterm labor in randomized studies. 3
Before Surgical Procedures
Treatment of BV (symptomatic or asymptomatic) before surgical abortion substantially reduces post-abortion pelvic inflammatory disease. 1, 2
- Consider treatment before other invasive procedures (endometrial biopsy, hysterectomy, IUD placement, cesarean section) as BV is associated with postoperative infectious complications. 1, 2